Organon

Organon

Yahoo Finance • last month

New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults1

The presentation at the 2026 Society for Pediatric Dermatology (SPD) Annual Meeting marked the first time pooled Phase 3 data from the ADORING 1 and 2 trials on Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD®) and... Full story

Yahoo Finance • last month

Organon & Co. Shareholders Clear Sun Pharma Merger Deal

Key Points Interested in Organon & Co.? Here are five stocks we like better. Organon shareholders approved the company's proposed merger with Sun Pharmaceutical Holdings USA, clearing a major step in the deal process. The transaction woul... Full story

Yahoo Finance • last month

Catalyst watch: Farnborough Air Show, Tesla earnings, AMD AI event, and Samsung reveals

[Skyline of Lower Manhattan] Art Wager Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - JULY 20... Full story

Yahoo Finance • 2 months ago

Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest

Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let's have a look at Zoetis (NYSE:ZTS) and its peers. Lo... Full story

Yahoo Finance • 2 months ago

Can Organon & Co. (OGN)’s MIUDELLA Launch Become a Major Driver in Women’s Health Markets?

We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Organon & Co. (NYSE:OGN) is one of the best low-priced pharma stocks on this list. TheFly reported on June 22 that OGN announced the completion of a glo... Full story

Yahoo Finance • 2 months ago

2 Biotech Stocks Worth Buying Before Their Potential Buyouts

Dealmaking is back with a vengeance in the pharmaceutical sector this year. According to a report by PwC, there were more than $65 billion in pharma and life sciences mergers & acquisitions in the first quarter, the best quarter for the se... Full story

Yahoo Finance • 2 months ago

Organon and Henlius launch Prolia and Xgeva biosimilars in Canada

* Organon Canada (OGN [https://seekingalpha.com/symbol/OGN]) and Shanghai Henlius Biotech on Tuesday announced [https://seekingalpha.com/pr/20559842-organon-canada-and-henlius-expand-access-to-denosumab-treatments-with-launch-of-bildyos]... Full story

Yahoo Finance • 2 months ago

Halper Sadeh LLC is Investigating Whether LPRO, NUVL, OGN, SUNE are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 3 months ago

Halper Sadeh LLC is Investigating Whether NUVL, SUNE, OGN, TMHC are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 3 months ago

State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?

The State Street SPDR S&P Pharmaceuticals ETF(NYSEMKT:XPH) offers a lower-cost entry into the drug manufacturing space, while the First Trust NYSE Arca Biotechnology Index Fund(NYSEMKT:FBT) provides concentrated exposure to biotechnology.... Full story

Yahoo Finance • 4 months ago

Insider trades: Intel, Bank of America, and Pinterest among notable names

A weekly overview of insider trading, highlighting significant purchases and sales by investors, directors, and executives. The transactions occurred between May 4, 2026, and May 8, 2026. * Intel (INTC [https://seekingalpha.com/symbol/I... Full story

Yahoo Finance • 4 months ago

Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 4 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

BALA CYNWYD, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Acke... Full story

Yahoo Finance • 4 months ago

Trending stocks this week as Big Tech earnings lift markets amid Fed pause

The stock market ended the week higher as investors worked through a wave of strong Big Tech earnings, while also navigating a divided Federal Reserve stance and renewed uncertainty in global oil markets. The Federal Reserve held its poli... Full story

Yahoo Finance • 4 months ago

Organon (OGN)’s Investors React Strongly as Sun Pharma Bets Big on Specialty Drug Expansion

After surging 119.70% so far in April, Organon & Co. (NYSE:OGN) secures a spot on our list of the mid-cap stocks with the highest gains in April.Organon (OGN)’s Investors React Strongly as Sun Pharma Bets Big on Specialty Drug Expansion A... Full story

Yahoo Finance • 4 months ago

Organon (NYSE:OGN) Misses Q1 CY2026 Revenue Estimates

Pharmaceutical company Organon (NYSE:OGN) missed Wall Street’s revenue expectations in Q1 CY2026, with sales falling 3.5% year on year to $1.46 billion. Its non-GAAP profit of $0.71 per share was 16.8% below analysts’ consensus estimates.... Full story

Yahoo Finance • 4 months ago

Micron initiated, Rambus downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Baird upgraded Old Dominion(ODFL) to Ne... Full story

Yahoo Finance • 4 months ago

Organon & Co. (OGN) Soars to 52-Week High on $11.75-Billion Sun Merger

Organon & Co. (NYSE:OGN) is one of the 10 Stocks Racking Up Monster Gains. Organon soared to a new 52-week high on Monday, as investors gobbled up shares after the company officially confirmed its planned $11.75-billion merger with Sun Ph... Full story

Yahoo Finance • 4 months ago

Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 4 months ago

Tech Earnings Optimism Powers Stocks Higher

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.12%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.13%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.01%.  June E-mini S&P futures (ESM26) rose +0.14%, and June E... Full story